<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
23:08
The strong storms in Bihor, Sibiu, and Brașov caused major damage, including torn roofs and fallen trees.
22:19
The Ministry of Energy has notified the European Commission about the severe drought affecting the Danube and the operation of the nuclear power plant in Cernavodă.
21:39
MAE, travel advisory for Japan: Typhoon Dolphin will bring strong gusts of wind and heavy precipitation in Okinawa
21:28
The Romanian team defeated Bulgaria 69-51 in the final quarter of the EuroBasket U18. Romania will play in the semifinals against the winner between Greece and Lithuania.
20:59
Volkswagen: Majority shareholders force a rapid restructuring after a sharp decline in Porsche SE's profit.
See more news